Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 46-1995761 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The mission of ilrog is to improve the outcome for patients by encouraging the appropriate integration of Radiation therapy in the management of Lymphoma. Ilrog objectives: - to optimize, advance and harmonize the integration of Radiation therapy in the management of Lymphoma patients. - to inform the hematology, medical and Radiation Oncology communities of the Lymphoma scenarios where appropriate utilization of Radiotherapy is advantageous. - to develop and disseminate evidence-based guidelines for Radiotherapy fields, doses and techniques for all types of lymphomas. - to train Radiation oncologists worldwide in using modern Lymphoma Radiotherapy principles and techniques via collaboration with appropriate national or regional scientific societies. - to provide a worldwide forum for Radiation oncologists who treat lymphomas to discuss and share information and ideas. - to provide a source of information for Lymphoma patients explaining the advantages and risks associated with radiati
Total Revenue
$85K
FY2024
Total Expenses
$73K
FY2024
Net Assets
$167K
Program Ratio
94.6%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.